Eden Research (LON:EDEN) Posts Quarterly Earnings Results

Eden Research (LON:EDENGet Free Report) issued its quarterly earnings data on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Price Performance

EDEN stock opened at GBX 2.19 on Wednesday. Eden Research has a 1 year low of GBX 1.96 and a 1 year high of GBX 5. The company has a debt-to-equity ratio of 1.43, a quick ratio of 2.42 and a current ratio of 2.25. The stock’s 50 day moving average price is GBX 2.73 and its 200 day moving average price is GBX 3.17. The firm has a market cap of £17.58 million, a P/E ratio of -4.94 and a beta of 1.57.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.

Read More

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.